Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial. (2020)
Attributed to:
MRC Centre for Reproductive Health at the University of Edinburgh
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(20)31693-7
PubMed Identifier: 32979978
Publication URI: http://europepmc.org/abstract/MED/32979978
Type: Journal Article/Review
Volume: 396
Parent Publication: Lancet (London, England)
Issue: 10255
ISSN: 0140-6736